Artificial Intelligence Strategies for Alzheimer's Disease Research
- Institution
- CEDARS-SINAI MEDICAL CENTER, CA
- Principal investigator
- Jason H. Moore
- Funding
- $1.6M
- Duration
- 2021–2026
Moonbase score
Still being scored
Abstract
Alzheimer's disease (AD) is a common disease that is partly due to protein misfolding and aggregation. Research on AD is a national priority with 5.5 million Americans affected at an annual cost of more than $250 billion and no available cure. This is despite heavy investments in the collection of diverse clinical and biological data in experimental and population-based studies. Artificial intelligence (AI) and machine learning have the potential to reveal patterns in clinical and multi-source large-scale Alzheimer’s data that have not been found using standard approaches. We propose here a comprehensive biomedical computing and health informatics research project to develop and apply cutting-edge AI algorithms and biomedical software for the analysis of large- scale AD data. At the heart of this proposed informatics program is the PennAI method and software for automating machine learning through an AI algorithm that can learn from prior analyses. This approach takes the guesswork out of picking the right machine learning algorithms and parameter settings thus making this computing technology accessible to everyone. Specifically, we will develop three novel informatics methods to tailor PennAI to the analysis of AD data. First, we will develop a Multi-Modal Interaction (M2I) feature selection algorithm for identifying genetic interactions that are predictive of AD (AIM 1). Second, we will develop a Knowledge-driven Multi-omics Integration (KMI) algorithm for combining omics features for AI analysis of AD (AIM 2). Third, we will develop a Multidimensional Brain Imaging Omics (MBIO) integration framework for the joint analysis of multi-source large-scale data for predicting AD. Finally, we will integrate all three biomedical informatics methods into our open-source PennAI software package and apply it to two large population-based studies of AD. We expect PennAI will reveal new biomarkers for AD that will open the door for better treatments and clinical decision support.
Research team
- Jason H. MoorePI
- Marylyn D RitchiePI
- Li ShenPI
LOADING MOONBASE SCORE
Questions for CEDARS-SINAI MEDICAL CENTER
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Cedars-Sinai Medical CenterNot yet scored
Resource Core 3 (RC3), Data Science
Jason H. Moore · $298K · 2025–2030
- NIH · Cedars-Sinai Medical CenterNot yet scored
AI Methods for Large Scale Epidemiological Studies using Patient Reports of Medication Adherence and Tolerability
Graciela Gonzalez Hernandez · $3.5M · 2025–2029
- NIH · Cedars-Sinai Medical CenterNot yet scored
Knowledge-guided automated machine learning methods for modeling the interaction of HIV with addictive drugs
Jason H. Moore · $491K · 2024–2029